Unilever plc (UL) is a publicly traded Consumer Defensive sector company. As of October 19, 2026, UL trades at $65.29 with a market cap of $142.48B and a P/E ratio of 0.00. UL moved -1.33% today. Year to date, UL is +1.16%; over the trailing twelve months it is -5.18%. Its 52-week range spans $54.75 to $74.98. Analyst consensus is strong buy with an average price target of $75.00. Rallies surfaces UL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Unilever agrees to sell Welly to Forward Consumer Partners: Unilever agreed to sell Welly Health, known for its colorful adhesive bandages, to Forward Consumer Partners for undisclosed terms. The deal is expected to close in the fourth quarter, subject to customary closing conditions.
| Metric | Value |
|---|---|
| Price | $65.29 |
| Market Cap | $142.48B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.53% |
| 52-Week High | $74.98 |
| 52-Week Low | $54.75 |
| Volume | 1.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover UL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $75.00.